User login
Pediatric Dermatology: Summer 2018
Effective Management and Counseling of Patients with Recurrent Bacterial Vaginosis
Click Here to Read Supplement.
Bacterial vaginosis (BV) affects women worldwide and recurrent BV can be a frustrating condition for both patients and providers. In this new supplement, expert Khady Diouf, MD, discusses her treatment approach and suggested counseling for patients with recurrent BV.
Click Here to Read Supplement.
Bacterial vaginosis (BV) affects women worldwide and recurrent BV can be a frustrating condition for both patients and providers. In this new supplement, expert Khady Diouf, MD, discusses her treatment approach and suggested counseling for patients with recurrent BV.
Click Here to Read Supplement.
Bacterial vaginosis (BV) affects women worldwide and recurrent BV can be a frustrating condition for both patients and providers. In this new supplement, expert Khady Diouf, MD, discusses her treatment approach and suggested counseling for patients with recurrent BV.
Neurology Board Review: Epilepsy
Click here to read Neurology Board Review: Epilepsy
Neurology Board Review: Epilepsy is a resource developed by leading clinical educators for studying for board certification and maintenance of certification exams.
After reading the article, Click Here to Access the Board Review Questions
About the Authors
Shavonne L. Massey, MD
Clinical Instructor
Departments of Neurology and Pediatrics
Children’s Hospital of Philadelphia
University of Pennsylvania
Philadelphia, Pennsylvania
Hannah C. Glass, MDCM, MAS
Associate Professor
Departments of Neurology, Pediatrics, and
Epidemiology & Biostatistics
University of California, San Francisco
San Francisco, California
Click here to read Neurology Board Review: Epilepsy
After reading the article, Click Here to Access the Board Review Questions
Click here to read Neurology Board Review: Epilepsy
Neurology Board Review: Epilepsy is a resource developed by leading clinical educators for studying for board certification and maintenance of certification exams.
After reading the article, Click Here to Access the Board Review Questions
About the Authors
Shavonne L. Massey, MD
Clinical Instructor
Departments of Neurology and Pediatrics
Children’s Hospital of Philadelphia
University of Pennsylvania
Philadelphia, Pennsylvania
Hannah C. Glass, MDCM, MAS
Associate Professor
Departments of Neurology, Pediatrics, and
Epidemiology & Biostatistics
University of California, San Francisco
San Francisco, California
Click here to read Neurology Board Review: Epilepsy
After reading the article, Click Here to Access the Board Review Questions
Click here to read Neurology Board Review: Epilepsy
Neurology Board Review: Epilepsy is a resource developed by leading clinical educators for studying for board certification and maintenance of certification exams.
After reading the article, Click Here to Access the Board Review Questions
About the Authors
Shavonne L. Massey, MD
Clinical Instructor
Departments of Neurology and Pediatrics
Children’s Hospital of Philadelphia
University of Pennsylvania
Philadelphia, Pennsylvania
Hannah C. Glass, MDCM, MAS
Associate Professor
Departments of Neurology, Pediatrics, and
Epidemiology & Biostatistics
University of California, San Francisco
San Francisco, California
Click here to read Neurology Board Review: Epilepsy
After reading the article, Click Here to Access the Board Review Questions
2018 CMSC Post Meeting Highlights
Three Clinical Studies Demonstrating Safety and Efficacy of Treatment for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) in Adults
In this supplement to Internal Medicine News, Christine Frissora, MD provides an overview of the burdens that patients with IBS-D experience. Three clinical efficacy and safety studies surrounding an FDA-approved treatment are also examined.
Topics include:
IBS-D diagnosis and treatment challenges
The role of microbial imbalance and altered gut microbiota
A treatment option for relief of IBS-D symptoms
XIFI.0273.USA.18
In this supplement to Internal Medicine News, Christine Frissora, MD provides an overview of the burdens that patients with IBS-D experience. Three clinical efficacy and safety studies surrounding an FDA-approved treatment are also examined.
Topics include:
IBS-D diagnosis and treatment challenges
The role of microbial imbalance and altered gut microbiota
A treatment option for relief of IBS-D symptoms
XIFI.0273.USA.18
In this supplement to Internal Medicine News, Christine Frissora, MD provides an overview of the burdens that patients with IBS-D experience. Three clinical efficacy and safety studies surrounding an FDA-approved treatment are also examined.
Topics include:
IBS-D diagnosis and treatment challenges
The role of microbial imbalance and altered gut microbiota
A treatment option for relief of IBS-D symptoms
XIFI.0273.USA.18
Reducing the Risk of Overt Hepatic Encephalopathy (HE) Recurrence and HE-Related Hospitalizations
In this supplement to The Hospitalist, Dr. Hameed Ali discusses HE and the importance of identifying and properly managing this common complication of cirrhosis.
Topics include:
- The various stages of HE
- The burden of HE and hospital readmission rates
- A medication for overt HE management
About the Author:
Hameed Q. Ali, DO, FHM
Clinical Assistant Professor
Department of Internal Medicine
Texas A&M Health Science Center
Temple, TX
XIF.0097.USA.18
In this supplement to The Hospitalist, Dr. Hameed Ali discusses HE and the importance of identifying and properly managing this common complication of cirrhosis.
Topics include:
- The various stages of HE
- The burden of HE and hospital readmission rates
- A medication for overt HE management
About the Author:
Hameed Q. Ali, DO, FHM
Clinical Assistant Professor
Department of Internal Medicine
Texas A&M Health Science Center
Temple, TX
XIF.0097.USA.18
In this supplement to The Hospitalist, Dr. Hameed Ali discusses HE and the importance of identifying and properly managing this common complication of cirrhosis.
Topics include:
- The various stages of HE
- The burden of HE and hospital readmission rates
- A medication for overt HE management
About the Author:
Hameed Q. Ali, DO, FHM
Clinical Assistant Professor
Department of Internal Medicine
Texas A&M Health Science Center
Temple, TX
XIF.0097.USA.18
Concerns in the Management of Chronic Heart Failure - Staying on the Path to Optimal Medical Therapy
Once-weekly Glucagon-like Peptide-1 Receptor Agonists
This supplement provides an overview of the role of once-weekly glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy in type 2 diabetes (T2D).
Topics include:
- Burden of illness in patients with T2D
- Pharmacokinetic properties and the mode and mechanism of action of GLP-1 RAs
- Safety and clinical efficacy of GLP-1 RAs
- Implications of cardiovascular outcomes trials in T2D
This supplement provides an overview of the role of once-weekly glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy in type 2 diabetes (T2D).
Topics include:
- Burden of illness in patients with T2D
- Pharmacokinetic properties and the mode and mechanism of action of GLP-1 RAs
- Safety and clinical efficacy of GLP-1 RAs
- Implications of cardiovascular outcomes trials in T2D
This supplement provides an overview of the role of once-weekly glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy in type 2 diabetes (T2D).
Topics include:
- Burden of illness in patients with T2D
- Pharmacokinetic properties and the mode and mechanism of action of GLP-1 RAs
- Safety and clinical efficacy of GLP-1 RAs
- Implications of cardiovascular outcomes trials in T2D
Neurology Board Review: Multiple Sclerosis
Click here to read Neurology Board Review: Multiple Sclerosis
Neurology Board Review: Multiple Sclerosis is a resource developed by leading clinical educators for studying for board certification and maintenance of certification exams.
After reading the article, Click Here to Access the Board Review Questions
About the Authors
Michael J. Bradshaw, MD
Clinical Fellow in Neurology
Partners Multiple Sclerosis Center
Brigham and Women’s Hospital
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts
Maria K. Houtchens, MD, MMSC
Director, Women’s Health Program
Partners Multiple Sclerosis Center
Brigham and Women’s Hospital
Harvard Medical School
Boston, Massachusetts
Click here to read Neurology Board Review: Multiple Sclerosis
After reading the article, Click Here to Access the Board Review Questions
Click here to read Neurology Board Review: Multiple Sclerosis
Neurology Board Review: Multiple Sclerosis is a resource developed by leading clinical educators for studying for board certification and maintenance of certification exams.
After reading the article, Click Here to Access the Board Review Questions
About the Authors
Michael J. Bradshaw, MD
Clinical Fellow in Neurology
Partners Multiple Sclerosis Center
Brigham and Women’s Hospital
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts
Maria K. Houtchens, MD, MMSC
Director, Women’s Health Program
Partners Multiple Sclerosis Center
Brigham and Women’s Hospital
Harvard Medical School
Boston, Massachusetts
Click here to read Neurology Board Review: Multiple Sclerosis
After reading the article, Click Here to Access the Board Review Questions
Click here to read Neurology Board Review: Multiple Sclerosis
Neurology Board Review: Multiple Sclerosis is a resource developed by leading clinical educators for studying for board certification and maintenance of certification exams.
After reading the article, Click Here to Access the Board Review Questions
About the Authors
Michael J. Bradshaw, MD
Clinical Fellow in Neurology
Partners Multiple Sclerosis Center
Brigham and Women’s Hospital
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts
Maria K. Houtchens, MD, MMSC
Director, Women’s Health Program
Partners Multiple Sclerosis Center
Brigham and Women’s Hospital
Harvard Medical School
Boston, Massachusetts
Click here to read Neurology Board Review: Multiple Sclerosis
After reading the article, Click Here to Access the Board Review Questions
